|CAS nie.:||84449-90-1||Wzór cząsteczkowy:||C28H27NO4S|
|Molekuła 33,46r Waga:||473,58||Użycie:||Wzrost mięśni|
|Wygląd:||Biały krystaliczny proszek||Gatunek:||Farmaceutycznej|
High Purity Steroid Powder Raloxifene CAS 84449-90-1 Evista with Discreet Package
Appearance:Light Yellow Powder
Raloxifene is a selective estrogen receptor modulator (SERM). It works in osteoporosis by decreasing bone breakdown and thinning that may occur in women after menopause. It works to decrease the risk of invasive breast cancer by blocking estrogen in breast and uterine tissue.
1.For the prevention and treatment of osteoporosis in postmenopausal women.
2.reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.
3.Reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.
Raloxifene is contraindicated in lactating women or women who are or may become pregnant, in women with active or past history of venous thromboembolic events, including deep vein thrombosis,pulmonary embolism, and retinal vein thrombosis and in women known to be hypersensitive to raloxifene.
Because of Raloxifene’s greater differences in its selectivity of Estrogen agonism and antagonism in different tissues in the body, there is ongoing investigation of its application in other diseases, including prostate cancer, acromegaly, uterine cancer, cardiovascular disease, and breast cancer.
Bodybuilders and anabolic steroid users are attracted to the use of Raloxifene due to its nature as an anti-estrogen in the fight against Estrogen-related side effects that are usually caused by the use of aromatizable androgens that result in high blood plasma levels of Estrogen in the body. A common estrogenic side effect as a result of this is the development of gnecomastia. In the realm of gynecomastia in particular, Raloxifene has actually demonstrated more promising effectiveness than Nolvadex (Tamoxifen).
As is common with all SERMs and anti-estrogens, Raloxifene has also demonstrated considerable benefit in stimulating endogenous natural Testosterone production in males, as studies have demonstrated an increase of serum Testosterone levels by 20% from 120mg of Raloxifene per day.
|17||Testosterone Cypionate||CAS: 58-20-8|
|18||Testosterone Decanoate||CAS: 5721-91-5|
|20||Testosterone Propionate||CAS: 57-85-2|
|21||Testosterone Phenylpropionate||CAS: 1255-49-8|
|22||Testosterone Isocaproate||CAS: 15262-86-9|
|23||Testosterone Undecanoate||CAS: 5949-44-0|
|26||Oral Turinabol||CAS: 2446-23-3|
|28||Nandrolone Cypionate||CAS: 601-63-8|
|29||Nandrolone Decanoate (DECA)||CAS: 360-70-3|
|30||Nandrolone Phenypropionate (NPP)||CAS: 62-90-8|
|35||Boldenone Acetate||CAS :2363-59-9|
|37||Boldenone Undecylenate||CAS: 13103-34-9|
|38||Drostanolone Propionate (Masteron)||CAS: 521-12-0|
|39||Drostanolone Enanthate||CAS: 472-61-1|
|40||Methenolone Acetate (Primobolan)||CAS: 434-05-9|
|41||Methenolone Enanthate||CAS: 303-42-4|
|42||Trenbolone Acetate||CAS: 10161-34-9|
|44||Trenbolone Hexahydrobenzyl Carbonate||CAS: 23454-33-3|